4.2 Article

Fecal transplant: A safe and sustainable clinical therapy for restoring intestinal microbial balance in human disease?

Journal

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.bpg.2013.03.003

Keywords

Fecal transplantation; Donor feces infusion; Bacteriotherapy; Intestinal microbiota transfer; Treatment; Probiotics; Autoimmune disease; Cardiovascular disease; Insulin resistance; Clostridium difficile

Funding

  1. TIFN [GH-003 2011]
  2. Netherlands Organization for Health Research and Development
  3. Dutch Heart Foundation (ZonMW, VEMI) [170881001]
  4. Dutch Heart Foundation (ZonMW, VENI) [016096044]
  5. Dutch Heart Foundation (CVON)

Ask authors/readers for more resources

Recent studies have suggested an association between intestinal microbiota composition and human disease, however causality remains to be proven. With hindsight, the application of fecal transplantation (FMT) does indeed suggest a causal relation between interfering with gut microbiota composition and a resultant cure of several disease states. In this review, we aim to show the available evidence regarding the involvement of intestinal microbiota and human (autoimmune) disease. Moreover, we refer to (mostly case report) studies showing beneficial or adverse effects of fecal transplantation on clinical outcomes in some of these disease states. If these findings can be substantiated in larger randomized controlled double blind trials also implementing gut microbiota composition before and after intervention, fecal transplantation might provide us with novel insights into causally related intestinal microbiota, that might be serve as future diagnostic and treatment targets in human disease. (C) 2013 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available